Jin Yang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Jin Yang Pharmaceutical has a total shareholder equity of ₩118.0B and total debt of ₩85.6B, which brings its debt-to-equity ratio to 72.5%. Its total assets and total liabilities are ₩227.6B and ₩109.6B respectively. Jin Yang Pharmaceutical's EBIT is ₩7.6B making its interest coverage ratio 5.7. It has cash and short-term investments of ₩4.2B.
Key information
72.5%
Debt to equity ratio
₩85.58b
Debt
| Interest coverage ratio | 5.7x |
| Cash | ₩4.16b |
| Equity | ₩118.02b |
| Total liabilities | ₩109.58b |
| Total assets | ₩227.60b |
Recent financial health updates
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11
Recent updates
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth
Aug 19These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit
May 23A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
Mar 22Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock
Mar 04These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 21Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?
Jan 04We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings
Dec 17Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching
Nov 30Financial Position Analysis
Short Term Liabilities: A007370's short term assets (₩43.7B) exceed its short term liabilities (₩20.7B).
Long Term Liabilities: A007370's short term assets (₩43.7B) do not cover its long term liabilities (₩88.9B).
Debt to Equity History and Analysis
Debt Level: A007370's net debt to equity ratio (69%) is considered high.
Reducing Debt: A007370's debt to equity ratio has increased from 21.1% to 72.5% over the past 5 years.
Debt Coverage: A007370's debt is not well covered by operating cash flow (18.3%).
Interest Coverage: A007370's interest payments on its debt are well covered by EBIT (5.7x coverage).